Research indicates that tirzepatide may produce greater weight loss than semaglutide at equivalent stages, making it a preferred choice for some patients
Liver Disease: Both Drugs May Reduce Risk Patients with Type 2 diabetes and chronic liver disease who took GLP-1s had a reduced risk of developing liver cancer and cirrhosisscarring of the livercompared to those who didnt take the drug, a Gut study found
In this post, well explore both delivery routes in detail, reviewing the pros, cons, mechanisms, and best-use cases for each formso you can make an informed decision about which may be right for you
Our goal is to provide you with a clear, science-backed roadmap for safe maintenance
Get a consultation and get your 1st Month of GLP-1 antagonist (4 pre-drawn syringes at the correct dosage for you) for just $199 , and $249/month thereafter no matter the dosage